rdf:type |
|
lifeskim:mentions |
umls-concept:C0009491,
umls-concept:C0017262,
umls-concept:C0023981,
umls-concept:C0036667,
umls-concept:C0185117,
umls-concept:C0312418,
umls-concept:C0681842,
umls-concept:C0699885,
umls-concept:C1182670,
umls-concept:C1304639,
umls-concept:C1332397,
umls-concept:C1579762,
umls-concept:C2911684
|
pubmed:dateCreated |
2011-2-7
|
pubmed:abstractText |
Local pelvic recurrence after radical cystectomy for muscle invasive bilharzial related squamous cell carcinoma accounts for 75% of treatment failures even in organ confined tumors. Despite the proven value of lymphadenectomy, up to 60% of patients undergoing cystectomy do not have it. These factors are in favor of adjuvant radiotherapy reevaluation. objectives: to evaluate the effect of adjuvant radiotherapy on disease free survival in muscle invasive bilharzial related squamous cell carcinoma of the urinary bladder and to test the predictability of radio-sensitivity using the anti apoptotic protein Bcl-XL.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-10606616,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-10658530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-11157016,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-11690683,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-11949826,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-1399731,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-14690486,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-1612951,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-16414487,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-17628309,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-18342927,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-18759990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-19520422,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-7673323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-7794804,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-8596636,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21226954-9224310
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1471-2407
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16
|
pubmed:dateRevised |
2011-7-25
|
pubmed:meshHeading |
pubmed-meshheading:21226954-Animals,
pubmed-meshheading:21226954-Carcinoma, Squamous Cell,
pubmed-meshheading:21226954-Cystectomy,
pubmed-meshheading:21226954-Female,
pubmed-meshheading:21226954-Humans,
pubmed-meshheading:21226954-Immunohistochemistry,
pubmed-meshheading:21226954-Kaplan-Meier Estimate,
pubmed-meshheading:21226954-Logistic Models,
pubmed-meshheading:21226954-Male,
pubmed-meshheading:21226954-Middle Aged,
pubmed-meshheading:21226954-Multivariate Analysis,
pubmed-meshheading:21226954-Predictive Value of Tests,
pubmed-meshheading:21226954-Prognosis,
pubmed-meshheading:21226954-Prospective Studies,
pubmed-meshheading:21226954-Radiotherapy, Adjuvant,
pubmed-meshheading:21226954-Radiotherapy Dosage,
pubmed-meshheading:21226954-Schistosomiasis,
pubmed-meshheading:21226954-Treatment Outcome,
pubmed-meshheading:21226954-Urinary Bladder Neoplasms,
pubmed-meshheading:21226954-bcl-X Protein
|
pubmed:year |
2011
|
pubmed:articleTitle |
Can Bcl-XL expression predict the radio sensitivity of bilharzial-related squamous bladder carcinoma? A prospective comparative study.
|
pubmed:affiliation |
Urology Department, Assiut University Hospital, Assiut, Egypt.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|